Data as of Apr 17
| -0.065 / -0.53%|
The 7 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 12.00. The median estimate represents a +38.55% increase from the last price of 12.27.
The current consensus among 9 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.